药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Levorphanol
Trimebutine
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Trimebutine.
Levorphanol
Vilanterol
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Vilanterol.
Levorphanol
Levocetirizine
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Levocetirizine.
Levorphanol
Hydroxychloroquine
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Hydroxychloroquine.
Levorphanol
Solifenacin
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Solifenacin.
Levorphanol
Sevoflurane
The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Lapatinib.
Levorphanol
Orphenadrine
The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Lapatinib.
Levorphanol
Perhexiline
The risk or severity of QTc prolongation can be increased when Perhexiline is combined with Lapatinib.
Levorphanol
Mequitazine
The risk or severity of QTc prolongation can be increased when Mequitazine is combined with Lapatinib.
Levorphanol
Tolterodine
The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Lapatinib.
Levorphanol
Salbutamol
The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Lapatinib.
Levorphanol
Alimemazine
The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Lapatinib.
Levorphanol
Inotersen
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Inotersen.
Levorphanol
Pipemidic acid
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Pipemidic acid.
Levorphanol
Rufloxacin
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Rufloxacin.
Levorphanol
Piromidic acid
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Piromidic acid.
Levorphanol
Lorajmine
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Lorajmine.
Levorphanol
Oxolinic acid
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Oxolinic acid.
Levorphanol
Prajmaline
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Prajmaline.
Levorphanol
Cibenzoline
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Cibenzoline.